Philips Appoints Jean Botti as Chief Innovation and Strategy Officer

PhilipsRoyal Philips (NYSE: PHG, AEX: PHIA) today announced the appointment of Jean Botti as Chief Innovation and Strategy Officer as part of the company's strategy to capture a larger portion of the HealthTech opportunities. Jean Botti, who will join Philips as of April 1, 2016 from Airbus Group (AIR), will become a member of Philips' Executive Committee and will report directly to Philips CEO Frans van Houten. Jean Botti will succeed Jim Andrew, who left Philips in the fourth quarter of 2015 for personal reasons.

"I am very pleased that Jean Botti has decided to join Philips on our journey to extending our leadership in health technology, capitalizing on opportunities arising from the consumerization and industrialization of healthcare to transform the delivery of care," said Frans van Houten. "Jean has had a remarkable and distinguished career and his achievements at Airbus are impressive, ranging from his ability to continually improve the company’s innovation capabilities and building intelligent systems, to embedding quality across the company’s value chain. His track record in driving innovation and change in high-tech industries will prove extremely valuable for Philips."

Jean Botti (French, 1957) joins Philips from Airbus Group, a global leader in aeronautics, space and related services, where he served as Chief Technical Officer since 2006. Prior to this, he worked in various roles in Europe and the U.S. at among others Renault and General Motors. He graduated from the National Institute of Applied Sciences (INSA) in Toulouse in 1986, with a degree in mechanical engineering. He holds a PhD in mechanical engineering from the Conservatoire des Arts et Métiers in collaboration with the University of Michigan. Jean Botti also earned an MBA from Central Michigan University and a degree in Research and Development Management from the Massachusetts Institute of Technology (MIT).

"I am excited to join a company that has made it its mission to improve the lives of billions of people every year globally and that has such a strong track record in innovation, advanced technologies and design capabilities," said Jean Botti. "I am convinced that my experience in the automotive and aviation industries in terms of digital transformation and process optimization will support Philips' ambitions to drive the personalization and industrialization of care."

The appointment of Jean Botti is the latest example of Philips' efforts to align its organization in order to better capitalize on HealthTech market opportunities.

Recently, and in addition to his role as CEO of Personal Health, Philips appointed Pieter Nota to the newly-created position of Chief Marketing Officer, whose role is to establish an integrated approach to marketing, building out Philips’ capabilities to drive marketing excellence in the rapidly changing world of health technology.

Furthermore, Philips established the Monitoring, Informatics & Connected Care segment, led by Jeroen Tas and comprising Patient Care & Monitoring Solutions, Healthcare Informatics, Emerging Businesses and a newly created Population Health Management business.

Related news articles:

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people’s lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2015 sales of EUR 24.2 billion and employs approximately 104,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare.

Most Popular Now

Zebra Announces Regulatory Approval of i…

Zebra Medical Vision, the leading machine learning imaging analytics company, announces that the company has been granted the CE approval and subsequent release of its Deep Learning Analytics Engine in...

Mind-Controlled Device Helps Stroke Pati…

Stroke patients who learned to use their minds to open and close a device fitted over their paralyzed hands gained some control over their hands, according to a new study...

Philips and Illumina Team Up with Navica…

Royal Philips (NYSE: PHG, AEX: PHIA) and Navican, an Intermountain Healthcare company, today signed an agreement to deploy a precision health informatics solution that will allow hospitals and health systems...

NHS Organisations to Access IMS MAXIMS C…

Award-winning electronic patient record (EPR) provider IMS MAXIMS has announced the availability of its cloud services on the latest iteration of the UK Government's G Cloud Framework. NHS organisations looking...

Boehringer Ingelheim Builds Digital Lab …

With the founding of BI X as independent subsidiary Boehringer Ingelheim will focus on breakthrough innovative digital solutions in healthcare from idea to pilot. The start-up will work closely together...

Artificial Intelligence to Assist in the…

The University of Tampere and TAYS (Tampere University Hospital) Heart Hospital use artificial intelligence (A.I.) technologies developed by VTT Technical Research Centre of Finland in the home care of heart...

Anyone can Become More Curious. Is that …

Merck, a leading science and technology company, today announced the start of an experiment entitled "Anyone can become more curious". Driven by the company’s curiosity initiative, which measured and described...

EC Open Call FETOPEN-01-2016-2017: FET-O…

The successful exploration of new foundations for radically new future technologies requires supporting a large set of early stage, high risk visionary science and technology projects to investigate new ideas...

Home Monitoring of Blood Sugar Did Not I…

Self-monitoring of blood glucose levels in patients with type 2 diabetes who are not treated with insulin did not improve glycemic control or health-related quality of life after one year...

Call for Applications: 2017 Lyfebulb-Nov…

For the second year in a row, Lyfebulb and Novo Nordisk will support international patient entrepreneurs who develop innovative ideas and concepts aimed to positively empower and impact the lives...

New Cellular Imaging Paves Way for Cance…

Researchers at the Universities of York and Leiden have pioneered a technique which uses florescent imaging to track the actions of key enzymes in cancer, genetic disorders and kidney disease...

UK PACS Win for Carestream Announced

West Hertfordshire Hospitals NHS Trust (West Herts) located in the South East of the UK and Carestream have signed and exchanged contracts to replace the Trust's existing PACS with a...